Publications
2004 Publications
Coppelli, FM, Grandis, JR. Oligonucleotides as Anticancer Agents: From the Benchside to the Clinic and Beyond. Curr Pharm Des:In press, 2004.
Gollin, SM. Chromosomal Instability. Curr Opin Oncol, 16(1):25-31, 2004.
Gollin, SM. Mechanisms Leading to Chromosomal Instability. Semin Cancer Biol:In press, 2004.
Grandis, JR, Sok, JC. Signaling through the Epidermal Growth Factor Receptor During the Development of Malignancy. Pharmacol Ther, 102(1):37-46, 2004.
Hoffelder, DR, Luo, L, Burke, NA, Watkins, SC, Gollin, SM, Saunders, WS. Resolution of Anaphase Bridges in Cancer Cells. Chromosoma, 112(8):389-397, 2004.
Kim, JW, Tsukishiro, T, Johnson, JT, Whiteside, TL. Expression of Pro- and Antiapoptotic Proteins in Circulating CD8+ T Cells of Patients with Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res, 10(15):5101-5110, 2004.
Li, S, Xu, J, Makarenkova, VP, Tjandrawan, T, Vakkila, J, Reichert, T, Gooding, W, Lagenaur, CF, Achim, CL, Chambers*, WH, Herberman, RB, Whiteside, TL, Vujanovic, NL. A Novel Epitope of N-CAM Defines Precursors of Human Adherent NK Cells. J Leukoc Biol, 2004.
Luo, LZ, Werner, KM, Gollin, SM, Saunders, WS. Cigarette Smoke Induces Anaphase Bridges and Genomic Imbalances in Normal Cells. Mutat Res, 554(1-2):375-385, 2004.
Myers, EN, Suen, JY, Myers, JN, Hanna, EYN. Cancer of the Head and Neck. 4th ed. Philadelphia: Elsevier Science; 2004.
Pomerantz, RG, Grandis, JR. The Epidermal Growth Factor Receptor Signaling Network in Head and Neck Carcinogenesis and Implications for Targeted Therapy. Semin Oncol:In press, 2004.
Reing, JE, Gollin, SM, Saunders, WS. The Occurrence of Chromosome Segregational Defects Is an Intrinsic and Heritable Property of Oral Squamous Cell Carcinoma Cell Lines. Cancer Genet Cytogenet, 150(1):57-61, 2004.
Reshmi, SC, Gollin, SM. Chromosomal Instability in Oral Cancer Cells. J Dent Res:In press, 2004.
Reshmi, SC, Saunders, WS, Kudla, DM, Ragin, CR, Gollin, SM. Chromosomal Instability and Marker Chromosome Evolution in Oral Squamous Cell Carcinoma. Genes Chromosomes Cancer, 41(1):38-46, 2004.
Saunders, W. Centrosomal Amplification and Spindle Multipolarity in Cancer Cells. Semin Cancer Biol:In press, 2004.
Thomas, SM, Grandis, JR. Pharmacokinetic and Pharmacodynamic Properties of EGFR Inhibitors under Clinical Investigation. Cancer Treat Rev, 30(3):255-268, 2004.
Vujanovic, NL. Testing Natural Killer Cells to Predict Cancer Outcome. In: Lotze, MT, Thomson, AW (eds). Measuring Immunity: The Immunology Surrogates Handbook: Academic Press: In press, 2004.
2003 Publications
Beitler, JJ, Johnson, JT. Transoral Laser Excision for Early Glottic Cancer. Int J Radiat Oncol Biol Phys, 56(4):1063-1066, 2003.
Ford, AC, Grandis, JR. Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer. Head Neck, 25(1):67-73, 2003.
Khalil, MY, Grandis, JR, Shin, DM. Targeting Epidermal Growth Factor Receptor: Novel Therapeutics in the Management of Cancer. Expert Rev Anticancer Ther, 3(3):367-380, 2003.
Magge, KT, Myers, EN, Johnson, JT. Radiation Following Surgery for Oral Cancer: Impact on Local Control. Laryngoscope, 113(6):933-935, 2003.
Niwa, H, Wentzel, AL, Li, M, Gooding, WE, Lui, VW, Grandis, JR. Antitumor Effects of Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res, 9(13):5028-5035, 2003.
Pomerantz, RG, Grandis, JR. The Role of Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma. Curr Oncol Rep, 5(2):140-146, 2003.
Riedel, F, Gotte, K, Li, M, Hormann, K, Grandis, JR. Abrogation of VEGF Expression in Human Head and Neck Squamous Cell Carcinoma Decreases Angiogenic Activity In Vitro and In Vivo. Int J Oncol, 23(3):577-583, 2003.
Saunders, W. Bridging Mitotic Defects and Clinical Diagnoses. Cancer Biol Ther, 2(3):253-255, 2003.
Simental, A, Johnson, JT, Horowitz, M. Delayed Complications of Endovascular Stenting for Carotid Blowout. Am J Otolaryngol, 24(6):417-419, 2003.
Simons, JP, Hunt, JL, Johnson, JT. Pathology Quiz Case. Granular Cell Tumor of the Tongue, with Extensive Overlying Pseudoepitheliomatous Hyperplasia. Arch Otolaryngol Head Neck Surg, 129(1):127-128, 2003.
Smith, JC, Johnson, JT, Cognetti, DM, Landsittel, DP, Gooding, WE, Cano, ER, Myers, EN. Quality of Life, Functional Outcome, and Costs of Early Glottic Cancer. Laryngoscope, 113(1):68-76, 2003.
Thomas, SM, Zeng, Q, Dyer, KF, Suscovich, TJ, Kanter, PM, Whalen, JD, Watkins, SF, Grandis, JR. Tissue Distribution of Liposome-Mediated Epidermal Growth Factor Receptor Antisense Gene Therapy. Cancer Gene Ther, 10(7):518-528, 2003.
Xi, S, Grandis, JR. Gene Therapy for the Treatment of Oral Squamous Cell Carcinoma. J Dent Res, 82(1):11-16, 2003.
Zimmer, LA, McCook, B, Meltzer, C, Fukui, M, Bascom, D, Snyderman, C, Townsend, DW, Johnson, JT. Combined Positron Emission Tomography/Computed Tomography Imaging of Recurrent Thyroid Cancer. Otolaryngol Head Neck Surg, 128(2):178-184, 2003.
2002 Publications
Hamilton, MK, Markovic, N. Implementing a Tobacco Cessation Program in the Pennsylvania Dental Practice. Pa Dent J (Harrisb), 69(5):38-40, 2002.
Hamilton, MK, Zajack, VL, Markovic, N. Update and Review: Oral Cancer Screening. Pa Dent J (Harrisb), 69(5):29-31, 2002.
Hoffmann, TK, Dworacki, G, Tsukihiro, T, Meidenbauer, N, Gooding, W, Johnson, JT, Whiteside, TL. Spontaneous Apoptosis of Circulating T Lymphocytes in Patients with Head and Neck Cancer and Its Clinical Importance. Clin Cancer Res, 8(8):2553-2562, 2002.
Hoffmann, TK, Muller-Berghaus, J, Ferris, RL, Johnson, JT, Storkus, WJ, Whiteside, TL. Alterations in the Frequency of Dendritic Cell Subsets in the Peripheral Circulation of Patients with Squamous Cell Carcinomas of the Head and Neck. Clin Cancer Res, 8(6):1787-1793, 2002.
Janjic, BM, Lu, G, Pimenov, A, Whiteside, TL, Storkus, WJ, Vujanovic, NL. Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. I. Involvement of an Apoptosis-Inducing Pathway. J Immunol, 168(4):1823-1830, 2002.
Li, M, Ye, C, Feng, C, Riedel, F, Liu, X, Zeng, Q, Grandis, JR. Enhanced Antiangiogenic Therapy of Squamous Cell Carcinoma by Combined Endostatin and Epidermal Growth Factor Receptor-Antisense Therapy. Clin Cancer Res, 8(11):3570-3578, 2002.
Lu, G, Janjic, BM, Janjic, J, Whiteside, TL, Storkus, WJ, Vujanovic, NL. Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. II. Role of TNF, Lymphotoxin-Alpha(1)Beta(2), FAS Ligand, and TNF-Related Apoptosis-Inducing Ligand. J Immunol, 168(4):1831-1839, 2002.
Lui, VW, Grandis, JR. EGFR-Mediated Cell Cycle Regulation. Anticancer Res, 22(1A):1-11, 2002.
Perlmutter, MA, Johnson, JT, Snyderman, CH, Cano, ER, Myers, EN. Functional Outcomes after Treatment of Squamous Cell Carcinoma of the Base of the Tongue. Arch Otolaryngol Head Neck Surg, 128(8):887-891, 2002.
Pitman, KT, Johnson, JT, Brown, ML, Myers, EN. Sentinel Lymph Node Biopsy in Head and Neck Squamous Cell Carcinoma. Laryngoscope, 112(12):2101-2113, 2002.
Riedel, F, Gotte, K, Li, M, Hormann, K, Grandis, JR. EGFR Antisense Treatment of Human HNSCC Cell Lines Down-Regulates VEGF Expression and Endothelial Cell Migration. Int J Oncol, 21(1):11-16, 2002.
Smith, JC, Johnson, JT, Myers, EN. Management and Outcome of Early Glottic Carcinoma. Otolaryngol Head Neck Surg, 126(4):356-364, 2002.
Zeng, Q, Kanter, PM, Dhir, R, Gooding, WE, Huang, L, Grandis, JR. Lack of Toxicity of EGFR Antisense Gene Therapy. J Exp Ther Oncol, 2(3):174-186, 2002.
Paraganglioma Publications
2004 Publications
Baysal, BE. Genomic Imprinting and Environment in Hereditary Paraganglioma. Am J Med Genet, 129C(1):85-90, 2004.
Baysal, BE, Willett-Brozick, JE, Filho, PA, Lawrence, EC, Myers, EN, Ferrell, RE. An Alu-Mediated Partial SDHC Deletion Causes Familial and Sporadic Paraganglioma. J Med Genet, 41(9):703-709, 2004.
Kant, JA, Uhrmacher, J, Baysal, BE, Monzon, FA, Carter, AB. Clinical Testing for Hereditary Paraganglioma. Am J Hum Genet:In press, 2004.
2003 Publications
Astrom, K, Cohen, JE, Willett-Brozick, JE, Aston, CE, Baysal, BE. Altitude Is a Phenotypic Modifier in Hereditary Paraganglioma Type 1: Evidence for an Oxygen-Sensing Defect. Hum Genet, 113(3):228-237, 2003.
Baysal, BE. On the Association of Succinate Dehydrogenase Mutations with Hereditary Paraganglioma. Trends Endocrinol Metab, 14(10):453-459, 2003.
2002 Publications
Baysal, BE. Hereditary Paraganglioma Targets Diverse Paraganglia. J Med Genet, 39(9):617-622, 2002.
Baysal, BE, Myers, EN. Etiopathogenesis and Clinical Presentation of Carotid Body Tumors. Microsc Res Tech, 59(3):256-261, 2002.
Baysal, BE, Willett-Brozick, JE, Lawrence, EC, Drovdlic, CM, Savul, SA, McLeod, DR, Yee, HA, Brackmann, DE, Slattery, WH, 3rd, Myers, EN, Ferrell, RE, Rubinstein, WS. Prevalence of SDHB, SDHC, and SDHD Germline Mutations in Clinic Patients with Head and Neck Paragangliomas. J Med Genet, 39(3):178-183, 2002.
Young, AL, Baysal, BE, Deb, A, Young, WF, Jr. Familial Malignant Catecholamine-Secreting Paraganglioma with Prolonged Survival Associated with Mutation in the Succinate Dehydrogenase B Gene. J Clin Endocrinol Metab, 87(9):4101-4105, 2002.